Research Library

Clinical Trial: Embarca Clinical Trial, National Breast Cancer Coalition is promoting. It's for BMN 673, a PARP Inhibitor for Advanced and/or Metastatic Breast Cancer Patients with a BRCA Mutation

Tagged in:

• breast cancer
• metastatic
• BRCA mutation

Go to URL

Added 19 Aug 2014

PUBLIC COMMENTS

There are currently no comments on this link.

Advertisements